Home
Conditions
Hemostatic Disorders

Clinical trial condition

Hemostatic Disorders

Explore clinical trials studying Hemostatic Disorders. Study availability and eligibility vary by location and protocol.

3,080 public trials 582 recruiting studies

Refine in advanced search Browse all conditions

Hemostatic Disorders trial results

Completed

Genetic Analysis of Patients With Pseudoxanthoma Elasticum

NCT00341419

Conditions: Cardiovascular Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +13 more
Locations: National Cancer Institute (NCI), 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma

NCT02958969

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Embolism and Thrombosis, +15 more
Locations: Brigham and Women's Hospital Boston, Massachusetts, United States

Vanderbilt University Medical Center Nashville, Tennessee, United States

View Trial Details

Completed

Vaccine Therapy With or Without Cyclophosphamide in Treating Patients With Recurrent or Refractory Multiple Myeloma

NCT00450814

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Veliparib, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory Lymphoma, Multiple Myeloma, or Solid Tumors

NCT01326702

Conditions: Adult B Acute Lymphoblastic Leukemia, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Adult Solid Neoplasm, +88 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Ixazomib in Combination With Thalidomide - Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma

NCT02410694

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Medizinische Universitätsklinik Graz, Klinische Abteilung für Hämatologie Graz, Styria, Austria

UK Innsbruck, Universitätsklinik für Innere Medizin, Klinische Abteilung für Hämatologie und Onkologie Innsbruck, Tyrol, Austria

A.ö. BK Kufstein, Abteilung für Innere Medizin Kufstein, Tyrol, Austria

Ordensklinikum, KH der Barmherzigen Schwestern Linz, Interne I: Internistische Onkologie, Hämatologie und Gastroenterologie Linz, Upper Austria, Austria

View all 17 locations

View Trial Details

Completed

Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer

NCT00003270

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +57 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Ph 2 Bortezomib, Dexamethasone, + Doxorubicin With ALCAR for Previously Treated Multiple Myeloma

NCT00581919

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Mercy Health Systems Janesville, Wisconsin, United States

Gundersen Lutheran La Crosse, Wisconsin, United States

University of Wisconsin Cancer Center Madison, Wisconsin, United States

Regional Cancer Center Waukesha/Oconomowoc, Wisconsin, United States

View Trial Details

Completed

Bone Marrow Transplant Studies for Safe and Effective Treatment of Leukemia

NCT00001623

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +33 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

MLN9708 (Ixazomib) in Combination With Panobinostat and Dexamethasone in Multiple Myeloma

NCT02057640

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations: University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

90 Y-BC8-DOTA Monoclonal Antibody, Fludarabine Phosphate, and Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Multiple Myeloma

NCT01503242

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Hemostatic Disorders

Hemostatic Disorders trial results

Related conditions